Annual Meeting of Stockholders - LEVI STRAUSS & CO

Explicit Guidance:

• None. The transcript is an Annual Meeting of Stockholders recording procedural events (quorum, director elections, corporate amendments) and does not contain financial guidance, earnings forecasts, revenue projections, or capital allocation targets.

Business-Segment Outlook:

• None. No discussion of product lines, geographic expansion, backlog, or specific segment performance was included.

Market and Competitive Outlook:

• None. No commentary on demand trends, pricing power, competitive dynamics, or market share shifts.

Macro / Industry Outlook:

• None. Management provided no analysis regarding the broader economy, interest rates, FX, regulation, or tariffs.

Strategic Initiatives:

• Authorization of New Shares: Approval granted to amend Articles of Incorporation to increase authorized common stock from 375 million to 1.0 billion shares.
  • Timing: Effective upon vote approval at the 2026 Annual Meeting (meeting date referenced as 2026).
• Standby Equity Purchase Agreement: Approval granted for the potential issuance of 20% or more of outstanding shares under a standby equity purchase agreement with YA2PN Limited.
  • Reference Date: Agreement dated March 24, 2026.
  • Purpose: Compliance with NASDAQ Listing Rule 5635D.
• Audit Firm Appointment: Ratification of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
• Corporate Governance: Election of three Class III directors (William Hazlitt, Michael Toporek, Daniel Golding) to serve three-year terms expiring at the 2029 Annual Meeting.

Risks and Headwinds to Outlook:

• Forward-Looking Statement Disclaimer: The CEO issued a general caution that any non-historical statements made during the meeting constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995.
• Risk Factors: Actual results may differ materially due to risks cited in recent 10-K and 10-Q filings. Specific risks were not enumerated in the transcript.
• Regulatory Limitation: Management explicitly noted the meeting is not a public forum for Regulation FD, meaning material non-public information (MNPI) regarding future prospects would not be disclosed.

Management Tone on the Future:

• Neutral/Procedural: The tone is strictly formal and administrative, focused on corporate governance compliance and shareholder voting mechanics rather than strategic vision or future financial performance.
• Confidence: No specific confidence levels or hedges regarding future performance were expressed; confidence was limited to the procedural approval of governance proposals.

Miscellaneous:

• Share Count Data: As of the record date (August 21, 2026), there were 246,702,047 shares of common stock outstanding.
• Proxy Mailing: Proxy materials were first mailed on or about August 24, 2026.
• SEC Reporting: Final voting results and Form 8-K reporting are scheduled to be completed within four business days following the meeting.
• Entity Name: The company is identified as "Saluna Holdings, Inc." (inferred from closing remarks).